U042 Think Again in Alopecia: Diagnostic Challenges and Pitfalls
DESCRIPTION
This Focus Session will provide dermatologists with a practical, case-based approach to avoiding diagnostic errors in alopecia. Faculty will highlight common mimickers, topographic clues, trichoscopic pitfalls, and clinicopathologic discordance in scarring and nonscarring alopecia. Emphasis will be placed on high-stakes distinctions that alter management, including overlapping disorders, subtle inflammatory findings, strategic biopsy selection, and presentations that may be more difficult to recognize in patients with skin of color. Attendees will leave with a more systematic approach to alopecia evaluation to improve diagnostic accuracy and help prevent irreversible hair loss.
LEARNING OBJECTIVES
Recognize common diagnostic pitfalls and mimickers in patients presenting with alopecia, including scenarios in which the initial diagnosis should be reconsidered.
Differentiate overlapping forms of alopecia by integrating history, scalp distribution, trichoscopy, and histopathologic findings.
Apply a practical clinicopathologic approach to biopsy selection and management decisions in patients at risk for delayed diagnosis and irreversible hair loss.
SCHEDULE
4:30 PM
Welcome and Introduction
Amy J. McMichael, MD, FAAD
4:32 PM
Scarring Alopecia in Disguise: Early Clues and Overlapping Diagnoses
Amy J. McMichael, MD, FAAD
4:44 PM
Shedding and Thinning: Diagnostic Traps and Treatment Pitfalls
Daniela Araucaria Guzman Sanchez, MD, IFAAD
4:56 PM
When Alopecia is More Than Hair Loss: Diagnostic Red Flags
Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD
5:08 PM
When the Biopsy Does Not Fit: Clinicopathologic Pearls for Practice
Melissa Piliang, MD, FAAD
5:20 PM
Questions and Answers
DIRECTOR
Amy J. McMichael, MD, FAAD
Wake Forest University School of Medicine
SPEAKERS
Daniela Araucaria Guzman Sanchez, MD, IFAAD
Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD
DISCLOSURES
Daniela Araucaria Guzman Sanchez, MD, IFAAD
Clinique – Advisory Board(Other Financial Benefit); DS Laboratories – Speaker(Honoraria); KPI Therapeutics, Inc. – Speaker(No Compensation Received); Omicron Lab – Investigator(Grants/Research Funding); Panalab – Speaker(Honoraria); Pierre Fabre – Speaker(Honoraria);
Jorge Felipe Larrondo Galvez, MD, MSc, IFAAD
No financial relationships exist with ineligible companies.
Amy J. McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);